Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TENET HEALTHCARE CORPTHC · Entity 2563 | EVP, Chief Admin. Officer & GC | March 09, 2026 | March 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TENET HEALTHCARE CORP
Report date March 09, 2026 · Filed March 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 12 |
Ending reported balance
After 2026-03-09 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-03-09 · Sale · Disposed 4,714 · Balance 3,298 F1: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $238.13 to $238.68. F2: The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Row 2 · 2026-03-09 · Sale · Disposed 3,286 · Balance 12 F2: The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F3: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $239.25 to $239.59. |
Filing footnotes · ownership attribution and instrument terms
F1: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $238.13 to $238.68.
F2: The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F3: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $239.25 to $239.59.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 19, 2023 Filed May 23, 2023 21:01 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 18,378 | $73.02 | $1,341,961.56 |
DisclosureSEC source: 0001209191-23-031689 · doc4.xml · nonDerivative · entry 1 Arnst Thomas W · CIK 0001852128 · EVP, Chief Admin. Officer & GC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,800 F1 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $72.62 to $73.61. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 22:34 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 1,600 | $60.07 | $96,112.00 |
DisclosureSEC source: 0001209191-23-017617 · doc4.xml · nonDerivative · entry 1 Arnst Thomas W · CIK 0001852128 · EVP, Chief Admin. Officer & GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,178 F1 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.12. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 02:19 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2020 February Performance-Based Restricted Stock Units · Derivative | 21,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017020 · doc4.xml · derivative · entry 13 Arnst Thomas W · CIK 0001852128 · EVP, Chief Admin. Officer & GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: On June 2, 2020, the reporting person received a target grant of 16,594 performance-based restricted stock units, scheduled to vest on February 28, 2023, subject to the Company's attainment of specified performance goals and the level of achievement thereof. The performance goals were exceeded, and the award was certified at a payout of 21,125 units. The performance-based restricted stock units settled on March 6, 2023. F10 · shares: The amount of performance-based restricted stock units received reflects a prior transfer of performance-based restricted stock units to the former spouse of the Reporting Person in accordance with the terms of a divorce agreement. F7 · derivative.exercise_date: On June 2, 2020, the reporting person received a target grant of 16,594 performance-based restricted stock units, scheduled to vest on February 28, 2023, subject to the Company's attainment of specified performance goals and the level of achievement thereof. The performance goals were exceeded, and the award was certified at a payout of 21,125 units. The performance-based restricted stock units settled on March 6, 2023. F7 · derivative.expiration_date: On June 2, 2020, the reporting person received a target grant of 16,594 performance-based restricted stock units, scheduled to vest on February 28, 2023, subject to the Company's attainment of specified performance goals and the level of achievement thereof. The performance goals were exceeded, and the award was certified at a payout of 21,125 units. The performance-based restricted stock units settled on March 6, 2023. F9 · derivative.underlying: Both time-based restricted stock units and performance-based restricted stock units are settled in shares of the Company's common stock. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 02:19 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2020 February Restricted Stock Units · Derivative | 5,531 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017020 · doc4.xml · derivative · entry 12 Arnst Thomas W · CIK 0001852128 · EVP, Chief Admin. Officer & GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,531 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on June 2, 2020, vest equally in one-third increments on February 28, 2021, February 28, 2022 and February 28, 2023, and the third and final 1/3 increment settled on March 6, 2023. F6 · derivative.exercise_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on June 2, 2020, vest equally in one-third increments on February 28, 2021, February 28, 2022 and February 28, 2023, and the third and final 1/3 increment settled on March 6, 2023. F6 · derivative.expiration_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on June 2, 2020, vest equally in one-third increments on February 28, 2021, February 28, 2022 and February 28, 2023, and the third and final 1/3 increment settled on March 6, 2023. F9 · derivative.underlying: Both time-based restricted stock units and performance-based restricted stock units are settled in shares of the Company's common stock. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 02:19 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2021 February Restricted Stock Units · Derivative | 3,869 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017020 · doc4.xml · derivative · entry 11 Arnst Thomas W · CIK 0001852128 · EVP, Chief Admin. Officer & GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,156 Underlying: Common Stock · 3,869 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2021, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the second 1/3 increment settled on March 6, 2023. F5 · derivative.exercise_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2021, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the second 1/3 increment settled on March 6, 2023. F5 · derivative.expiration_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2021, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the second 1/3 increment settled on March 6, 2023. F9 · derivative.underlying: Both time-based restricted stock units and performance-based restricted stock units are settled in shares of the Company's common stock. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 02:19 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2022 February Restricted Stock Units · Derivative | 4,213 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017020 · doc4.xml · derivative · entry 10 Arnst Thomas W · CIK 0001852128 · EVP, Chief Admin. Officer & GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,427 Underlying: Common Stock · 4,213 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 23, 2022, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the first 1/3 increment settled on March 6, 2023. F1 · derivative.exercise_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 23, 2022, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the first 1/3 increment settled on March 6, 2023. F1 · derivative.expiration_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 23, 2022, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the first 1/3 increment settled on March 6, 2023. F9 · derivative.underlying: Both time-based restricted stock units and performance-based restricted stock units are settled in shares of the Company's common stock. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 02:19 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 825 | $61.00 | $50,325.00 |
DisclosureSEC source: 0001209191-23-017020 · doc4.xml · nonDerivative · entry 9 Arnst Thomas W · CIK 0001852128 · EVP, Chief Admin. Officer & GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,778 F8 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $61.00 to $61.01. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 02:19 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 5,777 | $58.53 | $338,127.81 |
DisclosureSEC source: 0001209191-23-017020 · doc4.xml · nonDerivative · entry 8 Arnst Thomas W · CIK 0001852128 · EVP, Chief Admin. Officer & GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,603 F3 · shares: The transaction reported reflects the withholding of shares of common stock in satisfaction of the Reporting Person's tax liability in connection with the vesting and settlement of time-based restricted stock units and performance-based restricted stock units granted under the 2019 Stock Incentive Plan. F4 · price: Represents the closing price of the common stock of the Issuer on the vesting date. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 02:19 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 21,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-017020 · doc4.xml · nonDerivative · entry 7 Arnst Thomas W · CIK 0001852128 · EVP, Chief Admin. Officer & GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,380 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · security: On June 2, 2020, the reporting person received a target grant of 16,594 performance-based restricted stock units, scheduled to vest on February 28, 2023, subject to the Company's attainment of specified performance goals and the level of achievement thereof. The performance goals were exceeded, and the award was certified at a payout of 21,125 units. The performance-based restricted stock units settled on March 6, 2023. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 02:19 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 2,177 | $58.53 | $127,419.81 |
DisclosureSEC source: 0001209191-23-017020 · doc4.xml · nonDerivative · entry 6 Arnst Thomas W · CIK 0001852128 · EVP, Chief Admin. Officer & GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,255 F3 · shares: The transaction reported reflects the withholding of shares of common stock in satisfaction of the Reporting Person's tax liability in connection with the vesting and settlement of time-based restricted stock units and performance-based restricted stock units granted under the 2019 Stock Incentive Plan. F4 · price: Represents the closing price of the common stock of the Issuer on the vesting date. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 02:19 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 5,531 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-017020 · doc4.xml · nonDerivative · entry 5 Arnst Thomas W · CIK 0001852128 · EVP, Chief Admin. Officer & GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,432 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on June 2, 2020, vest equally in one-third increments on February 28, 2021, February 28, 2022 and February 28, 2023, and the third and final 1/3 increment settled on March 6, 2023. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 02:19 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 1,523 | $59.29 | $90,298.67 |
DisclosureSEC source: 0001209191-23-017020 · doc4.xml · nonDerivative · entry 4 Arnst Thomas W · CIK 0001852128 · EVP, Chief Admin. Officer & GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,901 F3 · shares: The transaction reported reflects the withholding of shares of common stock in satisfaction of the Reporting Person's tax liability in connection with the vesting and settlement of time-based restricted stock units and performance-based restricted stock units granted under the 2019 Stock Incentive Plan. F4 · price: Represents the closing price of the common stock of the Issuer on the vesting date. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 02:19 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 3,869 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-017020 · doc4.xml · nonDerivative · entry 3 Arnst Thomas W · CIK 0001852128 · EVP, Chief Admin. Officer & GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,424 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2021, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the second 1/3 increment settled on March 6, 2023. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 02:19 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 1,658 | $60.62 | $100,507.96 |
DisclosureSEC source: 0001209191-23-017020 · doc4.xml · nonDerivative · entry 2 Arnst Thomas W · CIK 0001852128 · EVP, Chief Admin. Officer & GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,555 F3 · shares: The transaction reported reflects the withholding of shares of common stock in satisfaction of the Reporting Person's tax liability in connection with the vesting and settlement of time-based restricted stock units and performance-based restricted stock units granted under the 2019 Stock Incentive Plan. F4 · price: Represents the closing price of the common stock of the Issuer on the vesting date. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 02:19 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 4,213 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-017020 · doc4.xml · nonDerivative · entry 1 Arnst Thomas W · CIK 0001852128 · EVP, Chief Admin. Officer & GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,213 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 23, 2022, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the first 1/3 increment settled on March 6, 2023. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:46 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Grant2023 March Restricted Stock Units · Derivative | 16,793 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-015841 · doc4.xml · derivative · entry 1 Arnst Thomas W · CIK 0001852128 · EVP, Chief Admin. Officer & GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,793 Underlying: Common Stock · 16,793 shares Expires not disclosed F1 · derivative.exercise_price: These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting. F1 · derivative.exercise_date: These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting. F1 · derivative.expiration_date: These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 21:25 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 8,742 | $88.00 | $769,296.00 |
DisclosureSEC source: 0001209191-22-016241 · doc4.xml · nonDerivative · entry 1 Arnst Thomas W · CIK 0001852128 · EVP, Chief Admin. Officer & GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 22:10 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2019 July Restricted Stock Units · Derivative | 4,972 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-014889 · doc4.xml · derivative · entry 6 Arnst Thomas W · CIK 0001852128 · EVP, Chief Admin. Officer & GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,972 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on July 9, 2019, and vest in full on February 28, 2022. F4 · derivative.exercise_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on July 9, 2019, and vest in full on February 28, 2022. F4 · derivative.expiration_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on July 9, 2019, and vest in full on February 28, 2022. F5 · derivative.underlying: Time-based restricted stock units are settled in shares of the Company's common stock upon vesting. F6 · balance_after: The amount of securities beneficially owned following the reported transaction reflects a prior transfer of securities to the former spouse of the reporting person in accordance with the terms of a divorce agreement. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 22:10 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2020 June Restricted Stock Units · Derivative | 4,379 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-014889 · doc4.xml · derivative · entry 5 Arnst Thomas W · CIK 0001852128 · EVP, Chief Admin. Officer & GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,531 Underlying: Common Stock · 4,379 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on June 2, 2020, and vest in one-half increments on February 28, 2022 and February 28, 2023. F1 · derivative.exercise_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on June 2, 2020, and vest in one-half increments on February 28, 2022 and February 28, 2023. F1 · derivative.expiration_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on June 2, 2020, and vest in one-half increments on February 28, 2022 and February 28, 2023. F5 · derivative.underlying: Time-based restricted stock units are settled in shares of the Company's common stock upon vesting. F6 · balance_after: The amount of securities beneficially owned following the reported transaction reflects a prior transfer of securities to the former spouse of the reporting person in accordance with the terms of a divorce agreement. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 22:10 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 1,786 | $85.99 | $153,578.14 |
DisclosureSEC source: 0001209191-22-014889 · doc4.xml · nonDerivative · entry 4 Arnst Thomas W · CIK 0001852128 · EVP, Chief Admin. Officer & GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,742 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 22:10 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 4,972 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-014889 · doc4.xml · nonDerivative · entry 3 Arnst Thomas W · CIK 0001852128 · EVP, Chief Admin. Officer & GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,528 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on July 9, 2019, and vest in full on February 28, 2022. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 22:10 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 1,067 | $85.99 | $91,751.33 |
DisclosureSEC source: 0001209191-22-014889 · doc4.xml · nonDerivative · entry 2 Arnst Thomas W · CIK 0001852128 · EVP, Chief Admin. Officer & GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,556 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 22:10 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 4,379 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-014889 · doc4.xml · nonDerivative · entry 1 Arnst Thomas W · CIK 0001852128 · EVP, Chief Admin. Officer & GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,623 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on June 2, 2020, and vest in one-half increments on February 28, 2022 and February 28, 2023. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 24, 2022 Filed Mar 1, 2022 00:02 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2021 February Restricted Stock Units · Derivative | 3,006 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-013784 · doc4.xml · derivative · entry 3 Arnst Thomas W · CIK 0001852128 · EVP, Chief Admin. Officer & GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,025 Underlying: Common Stock · 3,006 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2021, and vest equally in 1/3 increments on the first, second and third anniversaries of the grant date. F1 · derivative.exercise_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2021, and vest equally in 1/3 increments on the first, second and third anniversaries of the grant date. F1 · derivative.expiration_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2021, and vest equally in 1/3 increments on the first, second and third anniversaries of the grant date. F4 · derivative.underlying: Time-based restricted stock units are settled in shares of the Company's common stock upon vesting. F5 · balance_after: The amount of securities beneficially owned following the reported transaction reflects a prior transfer of securities to the former spouse of the reporting person in accordance with the terms of a divorce agreement. Read SEC document |
| February 24, 2022 Filed Mar 1, 2022 00:02 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 762 | $81.20 | $61,874.40 |
DisclosureSEC source: 0001209191-22-013784 · doc4.xml · nonDerivative · entry 2 Arnst Thomas W · CIK 0001852128 · EVP, Chief Admin. Officer & GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,244 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| February 24, 2022 Filed Mar 1, 2022 00:02 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 3,006 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-013784 · doc4.xml · nonDerivative · entry 1 Arnst Thomas W · CIK 0001852128 · EVP, Chief Admin. Officer & GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,006 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2021, and vest equally in 1/3 increments on the first, second and third anniversaries of the grant date. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 23:26 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Grant2022 February Restricted Stock Units · Derivative | 12,640 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-013321 · doc4.xml · derivative · entry 1 Arnst Thomas W · CIK 0001852128 · EVP, Chief Admin. Officer & GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,640 Underlying: Common Stock · 12,640 shares Expires not disclosed F1 · derivative.exercise_price: These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting. F1 · derivative.exercise_date: These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting. F1 · derivative.expiration_date: These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.